CytImmune Sciences' Unattributed - IV Round

CytImmune Sciences raised a round of funding on August 31, 2015.

CytImmune Sciences is a clinical stage nanomedicine company with a core focus on the discovery, development and commercialization of multifunctional, tumor-targeted therapies. Based on an R&D strategy…

Articles about CytImmune Sciences' Unattributed - IV Round: